InsidersTradesSigma
경보제약 Stock: price and insider trades · South Korea · DART (FSS)
Track the 경보제약 stock price and the full directors' dealings record of the company, a publicly traded company based in South Korea. Shares are listed on KR KR, under the oversight of DART (FSS). Operating in the Health Care sector, 경보제약 has logged 1 public disclosures. Market capitalisation: €124.6bn. The latest transaction was disclosed on 5 March 2026 (Purchase). Among the most active insiders: 정희록. All data is openly available.
1
Insider Decl.
0
Thresholds
€674
1 ops.
Buy Volume
·
0 ops.
Sell Volume
16Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 21,845 of 26,212 companies
28.0
score / 100
Value26
Quality30
FCF yld-27%
Earn yld0.1%
EV/EBITDA14.1x
ROE0.2%
Gross mgn39%
Net mgn0.1%
Debt/EBITDA7.1x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 5 March 2026